Pharmacy and Therapeutics Committee Updates

(From the March 2019 Issue of MedStat)

The following actions were taken at the 1/3/19  Pharmacy & Therapeutics Committee meeting:

  • The subcutaneous treprostinil policy was APPROVED
  • The South High Clinic Stock list change was APPROVED
  • The P&T Committee Goals for 2019 were APPROVED
  • The Transport Team Bag Update was APPROVED 

 The following actions were taken at the 2/7/19  Pharmacy & Therapeutics Committee meeting:

  • Updates to Lexi-Comp IV Administration Guidelines were APPROVED    
  • The Committee approach to biosimilar formulary decisions was APPROVED       
  • Baloxavir marboxil (Xofluza) was NOT ADDED to formulary                               
  • Zoster Vaccine, Recombinant (Shingrix) was ADDED to formulary                      
  • Pulmonary Clinic’s Stock List update was APPROVED                           
  • Nephrology Clinic - Dublin’s Stock List was APPROVED